Tight regulation of virus-induced cytotoxic effector CD8
+ T cells is essential to prevent immunopathology. Naturally occurring effector CD8 + T cells, with a KLRG1 hi CD62L lo phenotype typical of short-lived effector CD8 + T cells (SLECs), can be found in increased numbers in autoimmune-prone mice, most notably in mice homozygous for the san allele of Roquin. These SLEC-like cells were able to trigger autoimmune diabetes in a susceptible background. When Roquin is mutated (Roquin san ), effector CD8 + T cells accumulate in a cell-autonomous manner, most prominently as SLEC-like effectors. Excessive IFN-g promotes the accumulation of SLEC-like cells, increases their T-bet expression, and enhances their granzyme B production in vivo. We show that overexpression of IFN-g was caused by failed posttranscriptional repression of Ifng mRNA. This study identifies a novel mechanism that prevents accumulation of self-reactive cytotoxic effectors, highlighting the importance of regulating Ifng mRNA stability to maintain CD8 + T cell homeostasis and prevent CD8-mediated autoimmunity. The Journal of Immunology, 2012, 189: 000-000.
C ytotoxic CD8
+ effector T cells are an important component of the adaptive immune response against intracellular pathogens, including viruses, some bacteria, and tumor cells. As is true for other arms of the immune response, the trade off for being able to mount potent cytotoxic responses against pathogen-infected cells is the risk for autoimmunity. Breakdown in CD8 + T cell tolerance plays a major role in the development of type 1 diabetes and contributes to multiple sclerosis (1) (2) (3) (4) . Expansion of autoreactive CD8 + effector T cells has also been associated with other autoimmune diseases, including pancreatitis, autoimmune gastritis, inflammatory bowel disease, and systemic lupus erythematosus (5) (6) (7) (8) . Over the past few decades, we have gained considerable understanding about the cellular and molecular mechanisms that drive CD8 + effector T cell differentiation and clonal expansion during infection. There is relatively less known about the mechanisms that prevent expansion of self-reactive CD8 + T cells and/or their maturation into terminally differentiated effector cells.
CD8 + T cells responding to viral infections initiate their maturation into effector cells by upregulating the transcription factors T-bet and Eomesodermin (9-11). Terminal differentiation into CD8
+ short-lived effector cells (SLECs) requires further upregulation of T-bet and high expression of Blimp-1 (12) (13) (14) . The metabolic regulator mTOR plays a crucial role in CD8 + T cell development through its ability to sustain T-bet expression (15) . In addition to this important cell-autonomous transcriptional control of CD8 + T cell differentiation, extrinsic influences exerted by cytokines play a critical role in regulating CD8 + effector expansion, as well as survival. IL-15, either alone or together with IL-7, can promote the survival of SLECs and KLRG1 lo CD127 hi effector cells (12, 16) , respectively, during viral infections. IFN-g was shown to support the expansion of CD8 + effectors (17) . Contraction of effector cells is essential to maintain CD8 + T cell homeostasis and prevent accumulation of potentially self-or cross-reactive cells and immunopathology. This is particularly important because thymic clonal deletion ensures elimination of high-avidity self-reactive T cells but allows low-and intermediateavidity self-reactive T cells to escape to the periphery (18) . These can cause immunopathology if they are recruited into antiviral responses and fail to contract postinfection. In addition to T cell anergy, activation-induced cell death and the proapoptotic molecule Bim keep autoreactive CD8 + T cells in check (19) (20) (21) . Extrinsic mechanisms also operate to repress self-reactive T cells; these include availability of cytokines, such as IL-7 and IL-15 (22, 23) , and the suppressive effect of regulatory T cells through their ability to secrete IL-10 and TGF-b (24) . Although IFN-g was shown to promote CD8 + T cell apoptosis during viral infection (25) , a role for IFN-g in the regulation of self-reactive CD8 + T cell effectors has not been described.
In the absence of immunization, activated effector CD8 + T cells are found in mice bred in specific pathogen-free conditions, some of which express high amounts of the SLEC marker, KLRG1 (26) .
In a separate study, an effector CD122 lo and MHC class Idependent CD8 + population was also described in unimmunized mice (27) . It is unclear whether KLRG1 hi effector CD8 + T cells found in unimmunized mice can mediate autoimmune disease.
Roquin is a RING-1/CCCH-type zinc finger protein that controls the expression of ICOS (Icos) mRNA posttranscriptionally. Loss of Roquin, either specifically on T cells or in the hematopoietic system, caused expansion on CD8 + effector-like T cells but not autoimmunity (28) . In contrast, Roquin bearing the san allele, which is a gain-of-function-allele (29, data not shown), causes follicular helper T (Tfh) cell-dependent lupus (30) (31) (32) (33) ; it is achieved, at least in part, through posttranscriptional regulation of Icos mRNA. In this article, we show that sanroque mutation of Roquin causes the accumulation of naturally occurring KLRG1 hi CD8
+ effector cells, which can trigger autoimmune diabetes. The sanroque mutation causes failure of the posttranscriptional control of Ifng mRNA that leads to excessive IFN-g signaling, and this is a major driver of SLEC-like cell accumulation with enhanced effector features.
Materials and Methods

Mice
The mice were housed in specific pathogen-free conditions at the Australian National University Bioscience Facility. Roquin san/san C57BL/6 mice were crossed to Tbx21
Du/Du , OT-I, and Ifngr1 2/2 mice; Aire 2/2 , Cblb 2/2 , B6.
Yaa, and Fas
The/The mice are all on a C57BL/6 background. Fas The/The mice carry a loss-of-function point mutation at the Fas gene that results in high titers of antinuclear Ab (ANA + ) in the mice, as well as an accumulation of double-negative T cells in the periphery as the mice age; in these respects, they are very similar to the Fas lpr/lpr mice strain (L. Tze and C. Goodnow, unpublished observations). RIP-mOVA mice, which express membranebound OVA (mOVA) in their pancreatic b cells under the control of rat insulin promoter (RIP), were bred at the University of Melbourne, transferred to the Australian Bioscience Services for experiments, and allowed to acclimatize at this facility for 1 wk prior to injection. All animal procedures were approved by the Australian National University Animal Ethics and Experimentation Committee.
Bone marrow chimeras
Recipient mice were sublethally irradiated with 900 cGy (450 cGy in two doses) and were reconstituted via i.v. injection with 2 3 10 6 donor bone marrow cells.
OT-I cell preparation for adoptive transfer
OT-I T cells were purified from the spleens and pooled lymph nodes of OT-I mice (Roquin san/san or Roquin +/+ mice) using the CD8a + T cell Isolation kit II (MACS; Miltenyi Biotec). To transfer CD44 lo OT-I T cells, OT-I T cells were sorted from the spleens and pooled lymph nodes using a FACSAria (BD Biosciences).
Adoptive-transfer experiments
Purified OT-I cells were spiked with fixed numbers of B cells prior to i.v. injection into nonirradiated RIP-mOVA recipients. The urine of recipient mice was collected to assess glucosuria by Uristix (Bayer). Mice with glucose concentrations $55 mmol/l were considered diabetic.
Abs
All FACS Abs used were from BD Pharmingen, with the exception of anti-mouse CD8a-PE-Cy7 (53-6.7; BioLegend), anti-mouse KLRG1-allophycocyanin (2F1; eBioscience), anti-mouse KLRG1-PE-Cy7 (2F1; eBioscience), anti-mouse CD127 (IL-7Ra)-PE (A7R34; BioLegend), antimouse CD62L (L-selectin)-PerCP-Cy5.5 (MEL-14; eBioscience), antimouse/human CD44-Pacific Blue (IM7; BioLegend), anti-human/mouse T-bet-PerCP.Cy5.5 (4B10; eBioscience), and mouse anti-human granzyme B-PE (GB11; Invitrogen).
Flow cytometry
Spleen and lymph node cell suspensions were prepared by sieving and gentle pipetting. For surface staining, cells were maintained in the dark at 4˚C throughout. Cells were incubated in FACS buffer with each Ab for 20 min and washed thoroughly with FACS buffer. For intracellular staining, cells were fixed and permeabilized using the Mouse Regulatory T Cell Staining Kit (eBiosciences), following the manufacturer's instructions. Flow cytometers (FACSCalibur and LSR II; BD) and software (CellQuest or FACSDiva, respectively; BD) were used for the acquisition of flow cytometric data, and FlowJo software (Tree Star) was used for analysis.
In vitro stimulation
Splenocytes from unimmunized mice were stimulated with 500 ng/ml ionomycin, 50 ng/ml PMA, and 1:250 GolgiStop for 4 h at 37˚C before being subjected to IFN-g staining.
Histology
Pancreases were fixed in 10% neutral-buffered formalin, embedded in paraffin wax, sectioned at 4 mm thickness, dewaxed, and stained with H&E. 
Gene-expression profiling
In vitro cell activation
A total of 5 3 10 5 sorted CD44 lo CD8 + T cells was activated in the presence of 5 mg/ml anti-CD3 (BD Pharmingen), 2 mg/ml anti-CD28 (BD Pharmingen), and 10 ng/ml recombinant mouse IL-12p70 (eBioscience) for 16 h.
Actinomycin D treatment
The transcriptional inhibition reagent actinomycin D (10 mg/ml) was added to the media for resuspension of in vitro-activated CD8 + T cells. Cells in triplicate wells were harvested at 0, 0.5, 1, or 3 h. Cells were then subjected to RNA extraction with TRIzol reagent, followed by Ifng real-time PCR.
Real-time PCR
RNA was isolated with TRIzol reagent (Invitrogen). cDNA was synthesized using M-MLV Reverse Transcriptase (Invitrogen). Inventoried TaqMan Gene Expression Assays (Applied Biosystems) were used to amplify Tbx21 (Mm00450960_m1) and Gapdh (Mm99999915_g1) sequences. Ifng, Roquin, Hprt, and b-actin cDNA were amplified using Power SYBR Green PCR Master Mix (Applied Biosystems). Primers for Ifng were: 59-ACAG-CAAGGCGAAAAAGGAT-39 and 59-TGAGCTCATTGAATGCTTGG-39; primers for Roquin were: 59-CGTATTGATTGTATGTGATTGTG-39 and 59-AGCCATCTCTATTCTGACTC-39; primers for b-actin were: 59-TATG-GAATCCTGTGGCATC-39 and 59-GTGTTGGCATAGAGGTCTT-39; and primers for Hprt were: 59-AGCAGTACAGCCCCAAAATG-39 and 59-AGAGGTCCTTTTCACCAGCA-39. Real-time PCR was quantified with an ABI 7900 Prism, and fold changes in expression were determined by the 2 2DDCt method, with the results normalized to Hprt for Ifng, b-actin for Roquin, or Gapdh for Tbx21.
Statistical analyses
Data were analyzed using the Mann-Whitney U test, with the exception of bone marrow chimera and Ifng mRNA-expression experiments, for which the paired t test and unpaired t test was used, respectively. Unless otherwise stated, each symbol represents one mouse, and bars represent the median values for each group.
Results
SLEC-like CD8
+ T cells are increased in mice prone to autoimmune disease Terminally differentiated cytotoxic KLRG1 hi CD127 lo SLEC CD8 + T cells reacting to viral Ags are induced upon primary response to virus infection (12) . The existence of small numbers of KRLG1 hi CD8 + T cells, possibly reacting to self-Ag, in unimmunized healthy C57BL/6 mice (26, 27) , led us to hypothesize that their numbers would be higher in mouse strains prone to autoimmune disease. Given that these KRLG1 hi CD8 + T cells resembled virus-induced SLECs-they expressed low levels of CD62L, CD127, and CD122; at least 40% were in cell cycle (Ki-67 + ); and, unlike naive cells, died rapidly ex vivo in a manner comparable to virus-induced SLECs (Fig. 1A -C)-we refer to these cells hereafter as "SLEC-like" cells. We investigated SLEClike cell numbers in five strains of mice on a C57BL/6 background that develop severe (Roquin san/san ) or mild (Aire
Fas
The/The ) autoimmunity or fail to develop autoimmunity (B6. Yaa). Statistically significant increases in SLEC-like cells were found in the four strains that develop overt autoimmune symptoms ( Fig. 1D) but not in B6.Yaa mice; the Yaa gene by itself is unable to induce significant autoimmune responses in mice without the BXSB/MpJ background (34) . Among the mice prone to autoimmune disease, Roquin san/san mice, which were previously shown to develop lupus and be more susceptible to autoimmune diabetes (32) , had by far the highest proportion of SLEC-like CD8 + T cells, with an increase detected as early as 7 wk of age (Fig. 1D) (Fig. 2C) . Together, these indicate that the accumulation of Roquin san/san SLEC-like cells is CD8 + T cell intrinsic, and the nonhematopoietic system in Roquin san/san mice may enhance this effect.
Expansion of SLEC-like cells is associated with autoimmune diabetes
To investigate whether abnormal SLEC-like CD8 + T cell expansion in Roquin san/san mice may contribute to autoimmune diabetes, we investigated SLEC-like cell accumulation and diabetes induction after adoptive transfer of Roquin san/san OT-I cells into RIPmOVA mice (35) . In our study, injection .5 3 10 6 OT-I cells into nonirradiated RIP-mOVA recipients led to diabetes induction, whereas 2 3 10 6 OT-I cells rarely caused disease (data not shown). This is somewhat less efficient than originally reported (35) . To examine the effect of the san mutation at conditions unlikely to cause diabetes with wild-type cells, we injected 1 3 10 6 OT-I cells from either Roquin san/san or Roquin +/+ mice into nonirradiated RIP-mOVA recipients. The adoptively transferred OT-I cells were spiked with a fixed number of B cells to control for variations in the inoculum.
The phenotype of OT-I donor cells from young Roquin san/san and Roquin +/+ mice was investigated prior to transfer: only 0.5% KLRG1 hi cells were present in the Roquin san/san cell preparation; most of these were Va2 lo compared with 0.1% KLRG1 hi cells in the Roquin +/+ cells (data not shown). It should be noted that SLEC-like cells were significantly reduced in sanroque OT-I mice compared with non-TCR-transgenic mice (data not shown).
By (Fig. 3A, 3B ). In contrast, none of the RIPmOVA mice receiving Roquin +/+ OT-I cells developed diabetes, and all had intact islets with little or no lymphocytic infiltrate (Fig.  3A, 3B) 
SLEC-like CD8 + T cells. IFN-g and granzyme B are two important effector proteins for CD8
+ T cell-mediated killing. Intracellular flow cytometric staining revealed an ∼6-fold increase in the proportion of IFN-g-producing CD8
+ T cells, as well as a 2-fold increase in IFN-g expression on a per-cell basis among CD44 hi CD8 + T cells in Roquin san/san mice compared with wild-type littermates (Fig. 4A) . KLRG1
hi SLEC-like CD8 + T cells from Roquin san/san mice also expressed ∼2-fold higher amounts of granzyme B than did their wild-type counterparts (Fig. 4B) . To test whether accumulation of effector CD8 + T cells in the presence of Roquin san is a consequence of increased proliferation, cycling cells were enumerated by flow cytometry using Ki-67 staining. There was an ∼3-fold increase in the proportion of cycling SLEC-like CD8 + T cells in Roquin san/san mice compared with Roquin +/+ littermates; the naive CD44 lo CD8 + T cell compartment was unaffected (Fig. 4C) .
Several transcription factors were shown to play critical roles in the differentiation and function of SLECs (10, 11, 13) . To detect primary changes caused by the san mutation, we compared the gene-expression profiles of sorted naive Roquin san/san and Roquin +/+ CD8 + T cells. Naive cells were chosen to use in the comparative gene-expression profiling because KLRG1 was already upregulated in Roquin san/san naive CD8 + T cells (Fig. 4D) , and this approach had been successful in identifying Icos as one of the mRNAs responsible for Tfh cell accumulation within the CD4 + compartment (33) . Klrg1 mRNA was increased by 20-fold in naive Roquin san/san CD8 + T cells. Of the transcription factors known to influence effector/memory T cell differentiationEomesodermin (Eomes), Blimp (Prdm1), B cell lymphoma 6 (Bcl6), and T-bet (Tbx21)-Tbx21, a transcription factor required for terminal effector CD8 + T cell differentiation, was significantly upregulated (Fig. 4D ). This increase in T-bet within naive CD44 lo CD8
+ T cells was confirmed by real-time PCR and protein quantification by flow cytometry (Fig. 4D) . Taken together, these data suggest that Roquin san promotes the expression of IFN-g, granzyme B, and T-bet responsible for increased SLEC formation and function.
T-bet reduction deviates the accumulation of activated CD8 + T cells from SLEC-like cells to cells with a CD62L
lo KLRG1 lo phenotype T-bet was shown to cooperate with Eomes to regulate SLEC and memory CD8 + T cells (12, 36) , and overexpression of T-bet can enhance SLEC formation in response to viral infection (12) . Therefore, we hypothesized that the increased expression of T-bet observed above may cause the accumulation of self-reactive SLEClike cells. We first investigated whether decreasing the gene dose of T-bet would have an impact on SLEC-like cell numbers. To do this, we crossed sanroque mice with Duane mice. Duane mice are homozygous for a missense point mutation in Tbx21 (Tbx21
Du/Du
) that causes a reduction in T-bet protein, and the residual protein found in these mice is defective (37) . Decreasing the amount of T-bet did not decrease the accumulation of CD44 hi CD8 + T cells in Roquin san/san Tbx21 Du/Du mice that virtually lacked detectable T-bet protein (Fig. 5A, 5B) displaying an intermediate phenotype (Fig. 5C ). The decrease in SLEC-like cells upon T-bet dose reduction was accompanied by an increase in CD62L lo KLRG1 lo effector cells (Fig. 5C ). Together, these data indicate that T-bet reduction deviates the accumulation of activated CD8 + T cells from cells with a SLEC-like phenotype to CD62L lo KLRG1 lo effector cells but is not responsible for the accumulation of effector CD8 + T cells in sanroque mice.
T-bet reduction delays the onset of diabetes
We next examined whether reducing the expression of T-bet in OT-I cells became diabetic 24 h later. Granzyme B and IFN-g expression were still elevated in self-reactive Roquin san/san early effector cells, but their amounts were lower or comparable, respectively, to those of Roquin san/san SLEC-like cells (Fig. 5E, 5F ). Together, these findings suggest that Roquin san/san SLEC-like cells play a key role in causing autoimmune diabetes in RIP-mOVA mice, and diabetes can be delayed by reducing T-bet expression.
Excessive IFN-g signaling promotes the accumulation of Roquin san/san SLEC-like CD8 + T cells
The fact that T-bet reduction could not reverse the accumulation of effector CD8 + T cells in Roquin san/san mice prompted us to look into other causes. Roquin san/san CD4 + T cells were shown to produce excessive amounts of two cytokines known to influence CD8 + T cell homeostasis: IL-21 and IFN-g (32) . IL-21 is important for CD8 + T cell survival and memory formation (38, 39), whereas IFN-g promotes virus-specific CD8 + T cell expansion (17, 40) . Enumeration of SLEC-like cells in Roquin san/san mice deficient in IL-21 excluded dysregulation of this cytokine as the cause of SLEC-like cell accumulation in Roquin san/san mice (data not shown). Therefore, we investigated whether excessive IFN-g production could explain the SLEC-phenotype and aberrant expansion of Roquin san/san effector CD8 + T cells. Roquin san/san mice were crossed with mice lacking the IFN-g ligand-binding chain (also known as the a-chain) of the IFN-gR (Ifngr1 2/2 ). Loss of IFN-g signaling almost completely reversed the accumulation of Roquin san/san SLEC-like cells (Fig. 6A) Fig. 1) , suggesting that overproduction of IFN-g, as seen in Roquin san/san mice, perturbs SLEC-like cell homeostasis. Together, these results suggest that IFN-g is the predominant factor responsible for the expansion and accumulation of KLRG1 hi SLEC-like cells in Roquin san/san mice, but additional factors act to dysregulate this compartment (Fig. 6) .
We also assessed the ability of Roquin san/san CD8 + T cells deficient in IFN-g production to induce autoimmune diabetes in susceptible RIP-mOVA mice by transferring 1 million sorted CD44 Fig. 2 ). This result suggests that IFN-g overproduction contributes to the increased ability of Roquin san CD8 + T cells to induce autoimmunity in a susceptible host.
Excessive IFN-g promotes the overexpression of granzyme B and T-bet, as well as the proliferation of Roquin san/san effector CD8 + T cells
Having observed that Roquin san/san CD8 + effector T cells are more potent producers of granzyme B than are their wild-type counterparts (Fig. 4B) , we sought to determine whether this might be a consequence of excessive IFN-g production. Indeed, loss of IFN-g signaling completely normalized granzyme B production by SLEC-like cells to wild-type levels (Fig. 7A) .
IFN-g is required to upregulate T-bet in CD8 + T cells in an indirect manner upon virus infection (12, 41) . We wondered whether the increased expression of T-bet in Roquin san/san mice is a consequence of excessive IFN-g. To assess this, we measured Tbet mean fluorescence intensity (MFI) in naive (CD44 lo ) CD8 + T cells and SLEC-like cells from Roquin san/san mice deficient or not in IFN-gR1. In the absence of IFN-gR signaling, T-bet expression in Roquin san/san SLEC-like cells was comparable to that of Roquin +/+ mice (Fig. 7B) . A decrease in T-bet expression was also observed in the naive CD8 + T cell compartment in Roquin san/san Ifngr1 2/2 mice, although T-bet amounts were still higher than were those of Roquin +/+ mice (Fig. 7C) , suggesting that other factors contribute to elevated T-bet expression in naive CD8 + T cells. IFN-g was shown to promote Ag-specific CD8 + T cell expansion during viral infections (17, 40) , and we showed that Roquin san/san CD8 + T cells are hyperproliferative (Fig. 2C) . To formally test whether excessive IFN-g drives CD8 + effector T cell accumulation through enhancing their proliferation, cycling (Ki-67 + ) cells were enumerated. Proliferating CD8 + T cells were reduced by half in the absence of IFN-gR1 (Fig. 7D) . IFN-gR signaling acted on CD62L lo KLRG1 lo effector CD8 + T cells, whose proliferative rate was corrected with wild-type levels in mice lacking IFN-gR1, but it did not influence the proliferation of SLEC-like cells themselves (Fig. 7D) .
Together, these data suggest that excessive IFN-g predominantly acts by enhancing the cytotoxic potential and T- mice, which opposes the action of the RNA-binding ROQ and CCCH domains through a different mechanism (R. Ramiscal and C.G. Vinuesa, unpublished observations). Thus, it is likely that Roquin controls CD8 + T cell homeostasis through several mechanisms. This work allows dissection of the contribution of Roquinmediated RNA regulation to this effect.
Our work highlights the crucial role for posttranscriptional repression of Ifng mRNA in the control of naturally occurring CD8 + T cell effector cells, including those harboring self-reactivities. Failure to repress Ifng mRNA caused by the san mutation in Roquin is a major contributor to the aberrant accumulation of SLEC-like CD8 + T cell effectors. Posttranscriptional repression of IFN-g emerges as a powerful mechanism to control the expansion of highly cytotoxic SLEC-like cells.
A role for IFN-g as the principal effector cytokine of CD8 + T cell-mediated immunity has long since been established (42) . In the last decade, dual opposing roles for IFN-g in the homeostatic control of T cells were also described (17, 25, 40) : IFN-g limits the expansion of T cells through stimulating the expression of caspases downstream of Fas (25) , and, paradoxically, it can also enhance expansion of CD8 + T cell effector clones during viral infection (17) through an unknown molecular mechanism. Our study establishes a new role for IFN-g in the control of naturally occurring CD8 + T cell effectors and highlights the importance of controlled posttranscriptional regulation of this cytokine: IFN-g overproduction in the presence of Roquin san promotes the proliferation of KLRG1 lo effectors and the formation of highly cytotoxic SLEC-like cells and increases MHC-I expression on APCs, which promotes CD8 + T cell activation (Supplemental Fig. 3) .
Roquin was reported to bind to and repress Icos mRNA (29, 30, 33) ; prolonged Icos mRNA stability in the presence of Roquin san contributes to aberrant accumulation of CD4 + Tfh cells and lupus. The present work identifies IFN-g as a novel target of Roquin sanmediated repression. IFN-g is a cytokine known to be regulated posttranscriptionally: the RNA-binding protein tristetraprolin was reported to destabilize IFN-g mRNA (43) . Accumulation of Ifng mRNA causes excessive production of IFN-g, which acts, at least in part, to promote the expansion and accumulation of KLRG1 lo and terminally differentiated effector CD8 + T cells in Roquin san/san mice. In summary, we described a novel posttranscriptional mechanism operating to regulate SLEC-like cell homeostasis and prevent the accumulation of self-reactive CD8 + effectors, as well as their cytotoxic potential. Aberrant accumulation of highly cytotoxic SLEC-like cells, despite their short lifespan, can pose a threat for autoimmunity. Thus, manipulation of this axis to curtail the expansion and survival of self-reactive SLECs may be useful to dampen the pathological accumulation of these cells that is often seen in inflammatory diseases and that was shown in this study to contribute to autoimmune diabetes.
